Biotech Stock 365% This: Big Bet on 3-NDA Strategy
A focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
This analysis highlights how long-term returns vary across index funds, emphasizing the impact on portfolio resilience.
28,357 articlesA focused $8 million investment could trigger a dramatic move in a biotech stock. Learn how three NDA filings and a d...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
ARK Invest doubled down on SpaceX after a market pullback, funding the move by trimming Alibaba. The trade underscore...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
Markets steadied after the Supreme Court struck down sweeping tariffs, a move largely priced in by investors. Wall St...
A long-standing tax rule on Social Security benefits that was never inflation-indexed is now catching more middle-cla...
Broadcom's June earnings could upend market expectations. This deep-dive explains why the report may matter more than...
Executives from banking, asset management, and consulting gathered at Hampton Court Palace to launch a private-sector...
In a year of volatile rates, Vanguard’s cheapest short-term bond ETF stands out for ultra-low fees and solid near-ter...
If you keep cash in a basic checking or under the mattress, you may be missing out on meaningful growth. This guide s...
Rand Capital's Q1 2026 earnings set the tone for the year. This analysis breaks down the numbers, portfolio quality, ...
XLV faces a pivotal year as it tracking to beat the S&P 500 in 2026. Analysts say two factors that will decide its fa...